Luspatercept

ATC B03XA06 · 10 markets · 20 records

Luspatercept 10 markets · 20 records Forms

US 2 records · 2 strengths

CA 2 records · 2 strengths

AU 2 records · 2 strengths

  • 75 mginjectionREBLOZYL luspatercept 25 mg powder for injection vial also in US·ES·FR unknown
  • 25 mginjectionREBLOZYL luspatercept 25 mg powder for injection vial also in US·ES·FR unknown

SG 2 records · 2 strengths

ES 2 records · 2 strengths

TW 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名Reblozyl powder for solution for injection ×12芮寶喜凍晶注射劑 ×2芮寶興凍晶注射劑 ×2

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    HK 2 records · 1 strengths

      2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名Reblozyl powder for solution for injection ×6

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      FR 2 records · 2 strengths

      MX 1 records · 1 strengths

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        EU 1 records · 1 strengths

        EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

          1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
          The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

          Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

          A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.